QA: Alpine Immune Sciences INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2021_Alpine_Immune_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001626199, Alpine Immune Sciences INC

  xvar xval
0 AssetsCurrent 107,101,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,785,000
3 remainder_Assets 35,204,000
4 LiabilitiesCurrent 41,167,000
5 LiabilitiesNoncurrent 40,765,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,049,057
9 ResearchAndDevelopmentExpense 28,416,765
10 remainder_Expenses 576,920
11 remainder_Revenues 51,057,159
12 remainder_NetIncome 624,232
13 remainder_ComprehensiveNetIncome 36,665
  yvar yval
0 Assets 144,090,000
1 Liabilities 81,932,000
2 Expenses 40,042,742
3 Revenues 51,057,159
4 StockholdersEquity 62,158,000
5 NetIncome 11,638,649
6 ComprehensiveNetIncome 11,656,982
7 BaseVar 158,891,399
8 EconomicCapitalRatiobeforeLimitedLiability 1.30
9 EconomicCapitalRatio 2.53

Edgar->Model Mapping

Feature Distribution

Change over Time